A Review of Research on Drug Shortages in China
Lina Wu,FangYu,Caijun Yang,Qian Shen,Jie Chang,Wenwen Zhu,Dan Ye,Bing Lv,Shimin Yang
DOI: https://doi.org/10.16153/j.1002-7777.2016.05.009
2016-01-01
Abstract:Objective:To summarize the research status of drug shortages and to provide references for. Methods:The databases such as CNKI, Wan Fang Data and VIP were electronically searched to collect studies related to drug shortages and related issues such as the varieties, the reasons, strategies and so on. The retrieval was from January, 1989 to April, 2015.The literature was screened independently according to the inclusion and exclusion criteria, thendata were extracted and ifnallythe related studies were analyzed.Results:The varieties of drugs in-short in China added up to 148, including 126 kinds of chemical drugs and 22 kinds of traditional Chinese medicines. The chemical medicines in-short were mostly biological products, cardiovascular drugs, hematological system drugs, antimicrobial agents, antiphrastic drugs and so on. While the shortages of traditional Chinese medicineswere mostly internalmedicines. Moreover, reasons for the drug shortages in China were complicated, such as the unreasonable pricing policy, the unsound supporting measurements and bidding systems, loose supervision in relateddepartments and some institutional issues in hospital systems and lack of medical knowledge in patients. The strategies to deal with drug shortage includedestablishing special department and platform to manage drug shortages,formulatingguidelines to handle the problems, setting reasonable drug price and bidding policy, strengthening drugs registration,normalizing reservation of drugs in shortage and so on. Conclusion: Up to now, the status of drug shortages in China was not so optimistic. Drug shortages in China were varied, andthe analysis of the reasons was not profound enough.Furthermore, the strategies for solving related problems were superifcial and not in detail.What’s more, therewere few strategies toimprove this situation and few concerns about the impact of drug shortages. More studies about drug shortages were needed to provide support and advice.